Vethe NT - Search Results

1

Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial.

Kristiansen O, Vethe NT, Peersen K, Wang Fagerland M, Sverre E, Prunés Jensen E, Lindberg M, Gjertsen E, Gullestad L, Perk J, Dammen T, Bergan S, Husebye E, Otterstad JE, Munkhaugen J. Kristiansen O, et al. Among authors: vethe nt. Eur Heart J Cardiovasc Pharmacother. 2021 Nov 3;7(6):507-516. doi: 10.1093/ehjcvp/pvaa076. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32609361 Free PMC article. Clinical Trial.

2

Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.

Vethe NT, Mandla R, Line PD, Midtvedt K, Hartmann A, Bergan S. Vethe NT, et al. Scand J Clin Lab Invest. 2006;66(1):31-44. doi: 10.1080/00365510500420259. Scand J Clin Lab Invest. 2006. PMID: 16464785

3

Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.

Vethe NT, Bergan S. Vethe NT, et al. Ther Drug Monit. 2006 Oct;28(5):608-13. doi: 10.1097/01.ftd.0000245680.38143.ca. Ther Drug Monit. 2006. PMID: 17038874

4

Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.

Bremer S, Mandla R, Vethe NT, Rasmussen I, Rootwelt H, Line PD, Midtvedt K, Bergan S. Bremer S, et al. Among authors: vethe nt. Transplantation. 2008 Jan 15;85(1):55-61. doi: 10.1097/01.tp.0000296854.68123.03. Transplantation. 2008. PMID: 18192912

5

IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.

Vethe NT, Bremer S, Bergan S. Vethe NT, et al. Scand J Clin Lab Invest. 2008;68(4):277-85. doi: 10.1080/00365510701724871. Scand J Clin Lab Invest. 2008. PMID: 18609073

6

Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals.

Vethe NT, Bremer S, Rootwelt H, Bergan S. Vethe NT, et al. Ther Drug Monit. 2008 Dec;30(6):647-55. doi: 10.1097/FTD.0b013e31818955c3. Ther Drug Monit. 2008. PMID: 18806697 Clinical Trial.

7

Expression of IMPDH1 is regulated in response to mycophenolate concentration.

Bremer S, Vethe NT, Rootwelt H, Bergan S. Bremer S, et al. Among authors: vethe nt. Int Immunopharmacol. 2009 Feb;9(2):173-80. doi: 10.1016/j.intimp.2008.10.017. Epub 2008 Nov 20. Int Immunopharmacol. 2009. PMID: 19010451

8

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.

Bremer S, Vethe NT, Rootwelt H, Jørgensen PF, Stenstrøm J, Holdaas H, Midtvedt K, Bergan S. Bremer S, et al. Among authors: vethe nt. J Transl Med. 2009 Jul 27;7:64. doi: 10.1186/1479-5876-7-64. J Transl Med. 2009. PMID: 19635156 Free PMC article.

9

Determination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospray ionization and tandem mass spectrometry: assessment of matrix effects and assay performance.

Vethe NT, Gjerdalen LC, Bergan S. Vethe NT, et al. Scand J Clin Lab Invest. 2010 Dec;70(8):583-91. doi: 10.3109/00365513.2010.531141. Epub 2010 Nov 1. Scand J Clin Lab Invest. 2010. PMID: 21039189

10

Quantification of 6 glucocorticoids in human plasma by liquid chromatography tandem mass spectrometry: method development, validation, and assessment of matrix effects.

Sæves I, Vethe NT, Bergan S. Sæves I, et al. Among authors: vethe nt. Ther Drug Monit. 2011 Aug;33(4):402-10. doi: 10.1097/FTD.0b013e3182241799. Ther Drug Monit. 2011. PMID: 21743383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters